Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
B06AC05	TAKHZYRO	BioTech	Lanadelumab - 300mg/2ml		Injectable solution	1,204,227,927 L.L
L04AC13	TALTZ	BioTech	Ixekizumab - 80mg/ml	80mg/ml	Injectable solution	85,080,792 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	190,195,151 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 10mg/ml	10mg/ml	Injectable solution	95,166,436 L.L
L01FX24	TECVAYLI	BioTech	Teclistamab - 90mg/ml	90mg/ml	Injectable solution	483,720,518 L.L
L04AC16	TREMFYA	BioTech	Guselkumab - 100mg/ml	100mg/ml	Injectable solution	L.L
L01CX01	TRABECTEDIN EVER PHARMA	G	Trabectedin - 1mg	1mg	Injectable powder for concentrate for solution	88,574,985 L.L
S01EE04	TRAVONORM	G	Travoprost - 0.004%	0.004%	Drops	564,414 L.L
C09AA05	TRILTEC	G	Ramipril - 10mg	10mg	Capsule	575,933 L.L
S01EE04	TRAVOPROST BIOGARAN	G	Travoprost - 40mcg/ml	40mcg/ml	Drops solution	564,414 L.L
S01EE05	TAFLUPRO	G	Tafluprost - 0.0015%	0.0015%	Solution	1,912,288 L.L
C09BA03	TENSIKEY COMPLEX	G	Lisinopril - 20mg, Hydrochlorothiazide - 12.5mg		Tablet	536,193 L.L
S01FA06	TROPICIL TOP	G	Tropicamide - 10mg/ml	10mg/ml	Drops solution	200,233 L.L
C09BA05	TRILTEC PLUS	G	Ramipril - 10mg, Hydrochlorothiazide - 12.5mg		Tablet	2,243,577 L.L
C09BA05	TRILTEC PLUS	G	Ramipril - 5mg, Hydrochlorothiazide - 12.5mg		Tablet	2,189,823 L.L
C10AA05	TARDELIP	G	Atorvastatin - 10mg	10mg	Tablet, film coated	688,559 L.L
S01GA52	TRILLERG	G	Antazoline HCl - 0.5mg, Tetryzoline HCl - 0.4mg		Drops solution	310,428 L.L
C10AA05	TARDEN	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	688,559 L.L
L04AX07	TECFEO 240	G	Dimethyl Fumarate - 240mg	240mg	Capsule, delayed release	L.L
C10AA05	TORVACOL 10	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, coated	1,128,828 L.L
L04AA31	TERAGIO	G	Teriflunomide - 14mg	14mg	Tablet	L.L
C10AA05	TORVALIP 10	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	767,910 L.L
C10AA05	TOVAST	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	1,127,484 L.L
G04BD07	TOREDA	G	Tolterodine (tartrate) - 2mg	2mg	Tablet, film coated	2,311,409 L.L
C10AA05	TULIP	G	Atorvastatin (calcium) - 10mg	10mg	Tablet, film coated	899,031 L.L
R05CA12	TOUCALM	G	Dried Ivy leaf extract - 0.7g/100ml	0.7g/100ml	Syrup	300,765 L.L
C02CA06	TACHYBEN	G	Urapidil - 25mg/5ml	25mg/5ml	Injectable solution	1,439,255 L.L
J05AR12	TELADINE	G	Lamivudine - 300mg, Tenofovir disoproxil fumarate - 300mg		Tablet	17,454,739 L.L
C02KX01	TRACTAN	G	Bosentan (monohydrate) - 125mg	125mg	Tablet, film coated	47,747,570 L.L

...